Recent Posts
- Zemcelpro® (UM171 Cell Therapy) receives EC authorization as the first and only cell therapy for blood cancer patients without access to suitable donor cells
- Zemcelpro® (UM171 Cell Therapy) receives positive CHMP opinion for treatment of blood cancer patients without access to suitable donor cells
- ExCellThera Announces International Non-proprietary Name and New Orphan Drug Designation for UM171 Cell Therapy
- ExCellThera announces new UM171 data to be presented at ASH 2023
- UM171-Expanded Cell Therapy improves outcomes compared with other graft sources: Real-world evidence
Recent Comments
No comments to show.